SCHEMBL2316237

SCHEMBL2316237

O=C(CCCCCCCCCCSSCCCCCCCCCCC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O

nearest known ligand 0.37

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.37
KMT2A Q03164 1/20 0.37
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
GAA P10253 2/20 0.32
PSMB8 P28062 1/20 0.30
PSMB5 P28074 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2772797 1.00 SMN1; SMN2 (0.37) SMN1; SMN2KMT2AHPGDHTTGAA
SCHEMBL19611483 1.00 SMN1; SMN2 (0.37) SMN1; SMN2KMT2AHPGDHTTGAA
SCHEMBL5580899 1.00 SMN1; SMN2 (0.37) SMN1; SMN2KMT2AHPGDHTTGAA
SCHEMBL17430393 0.93 KMT2A (0.33) SMN1; SMN2KMT2APSMB8PSMB5LMNA
SCHEMBL19649646 0.93 KMT2A (0.47) SMN1; SMN2KMT2AGAA
SCHEMBL10077571 0.93 KMT2A (0.47) SMN1; SMN2KMT2AGAALMNA
SCHEMBL905722 0.89 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AHPGDHTTGAA
SCHEMBL1870550 0.89 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AHPGDHTTGAA
SCHEMBL4960230 0.89 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AHPGDHTTGAA
SCHEMBL379163 0.89 SMN1; SMN2 (0.42) SMN1; SMN2KMT2AHPGDHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12618834-B2 Measurement sample preparation method, analysis method, reagent, and reagent kit SYSMEX CORPORATION (JP) 2026-05-05 US claimed
EP-4053556-B1 MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT SYSMEX CORP (JP) 2025-05-21 EP claimed
US-20220283154-A1 MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT SYSMEX CORPORATION (JP) 2022-09-08 US claimed
EP-4053556-A1 MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT SYSMEX CORPORATION (JP) 2022-09-07 EP claimed
EP-3249050-B1 ENZYME ELECTRODE AND BIOSENSOR USING THE SAME ARKRAY INC (JP) 2019-01-23 EP claimed
US-12618834-B2 Measurement sample preparation method, analysis method, reagent, and reagent kit SYSMEX CORPORATION (JP) 2026-05-05 US disclosed
EP-4053556-B1 MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT SYSMEX CORP (JP) 2025-05-21 EP disclosed
US-20240410885-A1 QMAX ASSAYS AND APPLICATIONS ESSENLIX CORPORATION (US) 2024-12-12 US disclosed
US-12066434-B2 QMAX assays and applications ESSENLIX CORPORATION (US) 2024-08-20 US disclosed
US-20220283154-A1 MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT SYSMEX CORPORATION (JP) 2022-09-08 US disclosed
EP-4053556-A1 MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT SYSMEX CORPORATION (JP) 2022-09-07 EP disclosed
US-11083746-B2 Use of immobilization particles for removal of microorganisms and/or chemicals NUBIOME, INC. (US) 2021-08-10 US disclosed
US-20120108787-A1 Immobilization Particles for Removal of Microorganisms and/or Chemicals NUBIOME, INC. (US) 2012-05-03 US disclosed
US-20110223318-A1 METHOD FOR INTRODUCING FUNCTIONAL GROUP TO SURFACE OF MATERIAL KANGNUNG-WONJU NATIONAL UNIVERSITY INDUSTRY ACADEMY COOPERATION GROUP (KR) 2011-09-15 US disclosed
EP-2354146-A1 METHOD FOR INTRODUCING FUNCTIONAL GROUP TO SURFACE OF MATERIAL Kangnung-Wonju National University Industry Academy Cooperation Group (KR) 2011-08-10 EP disclosed
US-20100256343-A1 Immobilization particles for targeted removal of microorganisms and substances LUE BRIAN CHRISTOPHER 2010-10-07 US disclosed
US-20070148712-A1 Breast cancer and prostate cancer assessment IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2007-06-28 US disclosed
WO-2006133408-A9 BREAST CANCER AND PROSTATE CANCER ASSESSMENT UNIV IOWA STATE RES FOUND INC (US) 2007-04-12 WO disclosed
WO-2006133408-A2 BREAST CANCER AND PROSTATE CANCER ASSESSMENT IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 WO disclosed
US-20040082766-A1 Method of purifying biological substances, kit for purifying biological substances, and system for analyzing biological substances HITACHI, LTD. 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12618834-B2 Measurement sample preparation method, analysis method, reagent, and reagent kit CD63, SLC18A2, EXOSC5 SMN1; SMN2 1211/4885KMT2A 467/4885HPGD 4849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.